内皮作为抗瘤激酶抑制剂心血管毒性的来源
Richard J Travers1,2, Alec Stepanian1, Iris Z Jaffe1
1Molecular Cardiology Research Institute (R.J.T., A.S., I.Z.J.), Tufts Medical Center, Boston, MA.
Arteriosclerosis, thrombosis, and vascular biology
|August 15, 2024
概括
激酶抑制剂 (KIs) 对抗癌症,但可以通过破坏内皮细胞来损害心脏. 了解这种机制是预防向癌症疗法的心血管副作用的关键.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 分子生物学分子生物学
背景情况:
- 激酶抑制剂 (KIs) 是针对性的癌症疗法,副作用比化疗少.
- 心血管方面的副作用是许多向癌症治疗的重要限制.
- 内皮细胞对心血管健康至关重要,并暴露于全身抗癌药物.
研究的目的:
- 审查证据,将激酶抑制剂诱导的内皮细胞功能障碍与心血管毒性联系起来.
- 检查与内皮毒性相关的特定类型的KI.
主要方法:
- 临床前和临床研究的文献综述.
- 对内皮细胞中受KI影响的信号通路的分析.
- 检查与特定KI类相关的心血管毒性.
主要成果:
- 信号通路受到KIs的干扰,无论是在目标上还是目标之外,都可能导致内皮功能障碍.
- 血管内皮生长因子抑制剂,BCR-Abl KIs和布鲁顿氨酸抑制剂与内皮毒性有关.
- 新出现的数据表明,其他新的KI类也对内皮细胞构成风险.
结论:
- 内皮细胞功能障碍是各种激酶抑制剂心血管毒性的关键机制.
- 内皮是预防和潜在治疗向癌症治疗的心血管并发症的关键目标.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
145
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
145
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
Electron Transport Chain: Complex I and II
12.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.4K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


